Shelke S

Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, Cleveland, USA.

1 paper

ArticleKetamine

Evaluation of Current Evidence on the Efficacy of Esketamine in Treating Substance-Use Disorders in Patients With Treatment-Resistant Depression (TRD): A Narrative Review.

Shelke S, Thummalapally RR